Bayer Pharmaceuticals

Bayer, one of the world’s leading pharmaceutical companies, is committed to advancing prostate cancer research by supporting early-career investigators and scientific teams. In 2024, Bayer funded two PCF Young Investigators—promising researchers dedicated to driving innovation and improving outcomes for patients.

Through this support, Bayer helps nurture the next generation of leaders in cancer research while accelerating progress toward new treatments and cures.

To learn more, visit www.bayer.com